RxDoctor Payments Data

Elizabeth McLeish, PA

Physician Assistant · Plymouth, MANPI 1013929389

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 514 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 25.2% of the total. Among physician assistant clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,360in general payments, 2019–2025

Across 514 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Sanofi$903
  • Novartis$774
  • Amgen$556
  • plus $3K from 18 others

What the payments were for

  • Food & beverage$9,99997%
  • Education$3613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,360 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$258,270
Medicare patients
1,537
Services billed
5,577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate86$5,946
Fluorouracil51$2,661
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc87$2,613
Betamethasone Dipropionate67$2,427
Metronidazole44$1,953
Triamcinolone Acetonide149$1,837
Ketoconazole57$1,086
Doxycycline Hyclate57$998
Tretinoin12$534
Clindamycin Phosphate15$354
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet13$322
Fluocinonide11$259
Mupirocin38$237
Nystatin12$169
ValacyclovirValacyclovir Hcl13$110

Paid to pharmacies, not to this prescriber.

Other physician assistant in Plymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →